HOXD-AS2 Gene

Name HOXD cluster antisense RNA 2
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n HOXD‐AS2 is an oncogenic long non‐coding RNA that has been implicated in several cancer types, most notably in glioblastoma and lung adenocarcinoma. In glioma, HOXD‐AS2 is markedly upregulated and its overexpression is associated with higher tumor grade and poor prognosis. Functional studies have demonstrated that silencing HOXD‐AS2 suppresses cell proliferation, migration, and invasion, while promoting apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In addition, HOXD‐AS2 contributes to the reorganization of chromatin architecture of the HOXD locus in glioma cells. Acting in concert with another lncRNA, LINC01116, HOXD‐AS2 facilitates CTCF/cohesin‐mediated looping that results in coactivation of miR‐10b and multiple HOXD genes, thus promoting neoplastic transformation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, HOXD‐AS2 has been implicated in chemoresistance mechanisms. In glioblastoma cells treated with temozolomide, TGF‐β/Smad signaling upregulates HOXD‐AS2 along with H19, leading to competitive binding with the RNA‐binding protein KSRP and preventing the maturation of miR‐198. The resulting decrease in miR‐198 levels causes an increase in MGMT expression, thereby promoting temozolomide resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Similarly, in lung adenocarcinoma, ceRNA network analyses suggest that HOXD‐AS2 may act as a molecular sponge that contributes to cisplatin resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, differential expression patterns of HOXD‐AS2 in normal tissues further underscore its potential role in tissue‐specific regulation. For example, in normal colorectal mucosa, HOXD‐AS2 is expressed at significantly higher levels in the sigmoid colon compared with the rectum, suggesting that the HOXD cluster, including HOXD‐AS2, may participate in regional gene expression programs."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings highlight the multifaceted role of HOXD‐AS2 in promoting tumor progression, mediating chemoresistance, and influencing chromatin architecture and tissue‐specific gene expression. Its oncogenic functions and regulatory interactions underscore its potential as a diagnostic marker and therapeutic target in various cancers.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xingming Zhong, Yong Cai "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1977104"}], "href": "https://doi.org/10.1080/21655979.2021.1977104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34802389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34802389"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yingjiao Qi, Zhixing Wang, Fan Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HOXD-AS2 regulates cell cycle to promote glioma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28117"}], "href": "https://doi.org/10.1002/jcb.28117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30485495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30485495"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Evgeny Deforzh, Erik J Uhlmann, Eashita Das, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2022.03.018"}], "href": "https://doi.org/10.1016/j.molcel.2022.03.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35390275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35390275"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Er Nie, Xin Jin, Faan Miao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuro Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/neuonc/noaa198"}], "href": "https://doi.org/10.1093/neuonc/noaa198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32813021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32813021"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yepeng Li, Shiqing Huang, Zhongheng Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Lett (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ol.2020.11483"}], "href": "https://doi.org/10.3892/ol.2020.11483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32382346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32382346"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jason M Knight, Eunji Kim, Ivan Ivanov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive site-specific whole genome profiling of stromal and epithelial colonic gene signatures in human sigmoid colon and rectal tissue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Physiol Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/physiolgenomics.00023.2016"}], "href": "https://doi.org/10.1152/physiolgenomics.00023.2016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27401218"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27401218"}]}]}]}
NCBI Gene ID 100506783
API
Download Associations
Predicted Functions View HOXD-AS2's ARCHS4 Predicted Functions.
Co-expressed Genes View HOXD-AS2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View HOXD-AS2's ARCHS4 Predicted Functions.

Functional Associations

HOXD-AS2 has 364 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.

Click the + buttons to view associations for HOXD-AS2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of HOXD-AS2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of HOXD-AS2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of HOXD-AS2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of HOXD-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of HOXD-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of HOXD-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of HOXD-AS2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of HOXD-AS2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GWASdb SNP-Disease Associations diseases associated with HOXD-AS2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with HOXD-AS2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of HOXD-AS2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of HOXD-AS2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.